WUXI BIO (02269): Miao Jingwen appointed as non-executive director.
Wu Yibing, Ph.D., has resigned as of November 20, 2024, in an announcement from WuXi Biologics (02269).
WUXI BIO (02269) announces that, effective from November 20, 2024, Dr. Wu Yibing has resigned as a non-executive director and member of the Board's decision-making committee to dedicate more time to other personal matters. Ms. Miao Jingwen has been appointed as a non-executive director and member of the decision-making committee.
Related Articles
Ahsay Backup (08290) announces a pleasing profit growth, with an anticipated annual net profit not exceeding 1 million Hong Kong dollars in 2025, turning from a loss to a profit year-on-year.
Dalian Zhiyun Automation (300097.SZ) plans to raise funds of up to 250 million yuan through a private placement to its controlling shareholder Huida Fuheng.
STERLING GP (01825) reduced 373 million shares due to a 10-for-1 consolidation.
Ahsay Backup (08290) announces a pleasing profit growth, with an anticipated annual net profit not exceeding 1 million Hong Kong dollars in 2025, turning from a loss to a profit year-on-year.
Dalian Zhiyun Automation (300097.SZ) plans to raise funds of up to 250 million yuan through a private placement to its controlling shareholder Huida Fuheng.
STERLING GP (01825) reduced 373 million shares due to a 10-for-1 consolidation.
